Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope
Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. 27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines...
Saved in:
Published in | Immune network Vol. 10; no. 6; pp. 239 - 246 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
대한면역학회
01.12.2010
The Korean Association of Immunologists |
Subjects | |
Online Access | Get full text |
ISSN | 1598-2629 2092-6685 2092-6685 |
DOI | 10.4110/in.2010.10.6.239 |
Cover
Abstract | Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.
27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done.
Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity.
A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed. |
---|---|
AbstractList | Background: Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. Methods: 27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done. Results: Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity. Conclusion: A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed. KCI Citation Count: 0 Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. 27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done. Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity. A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed. Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.BACKGROUNDMonoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done.METHODS27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done.Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity.RESULTSOnly KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity.A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed.CONCLUSIONA novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed. |
Author | Ji, Gil-Yong Yoon, Sang-Soon Kim, Jong-Suk Lee, Ok-Jun Son, Bo-Ra Song, Hyung-Geun Lee, Dong-Geun Hong, Kwon-Pyo Kang, Sung-Hee Lee, Kyoung-Mee |
AuthorAffiliation | 3 Department of Laboratory Medicine, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea 1 Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea 2 Research Institute, DiNonA Inc, Iksan 570-912, Korea 4 Department of Plastic and Reconstructive Surgery, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea |
AuthorAffiliation_xml | – name: 2 Research Institute, DiNonA Inc, Iksan 570-912, Korea – name: 4 Department of Plastic and Reconstructive Surgery, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea – name: 1 Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea – name: 3 Department of Laboratory Medicine, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea |
Author_xml | – sequence: 1 fullname: Hong, Kwon-Pyo – sequence: 2 fullname: Kang, Sung-Hee – sequence: 3 fullname: Lee, Kyoung-Mee – sequence: 4 fullname: Ji, Gil-Yong – sequence: 5 fullname: Yoon, Sang-Soon – sequence: 6 fullname: Kim, Jong-Suk – sequence: 7 fullname: Son, Bo-Ra – sequence: 8 fullname: Lee, Dong-Geun – sequence: 9 fullname: Lee, Ok-Jun – sequence: 10 fullname: Song, Hyung-Geun |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21286385$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001518585$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kUtr3DAUhUVJaSZp910VbUrTxUz1sGRrUxicaceQJhDStbiW5YkajzSx7EDy66t5JLRdFAQXoe-cg-45QUc-eIvQe0pmGaXki_MzRtIlHTljXL1CE0YUm0pZiCM0oUIVUyaZOkYnMf4iRGY8F2_QMaOskLwQE6TLW-jBDLZ3TzC44HFoMeDL8GA7_CP4YLrgocNzP7g6NI_4jOVL9hlfWxNW3j05v8LLcQ0el-c8w2UHMeKqqvBi44awsW_R6xa6aN8d5in6-W1xUy6nF1ffq3J-MTWccDU1KmOsZTmRioncUlm0NQCRBWlymbdARZMbmhnJRQ68ZgpEI6HOAAqSKWr4KTrb-_q-1XfG6QBuN1dB3_V6fn1TabaNEgn9ukc3Y722jbF-6KHTm96toX_cCf9-8e422TxoTphUWZYMPh0M-nA_2jjotYvGdh14G8aoi0ylUgiVifzwZ9RLxvP-EyD3gOlDjL1ttXHDroeU7DpNid4WrZ3X26K3d5n-oZKQ_CN89v6P5ONhRWNCbePgRXN5db4gkiuWc8F_A4_StRg |
CitedBy_id | crossref_primary_10_1016_j_biomaterials_2015_07_012 |
Cites_doi | 10.1016/0145-2126(85)90016-5 10.1200/JCO.1994.12.1.28 10.1016/S0022-1759(97)00045-8 10.1002/(SICI)1097-0320(19960615)26:2<154::AID-CYTO9>3.0.CO;2-G 10.1182/blood.V75.12.2417.2417 10.1089/scd.1.1992.1.115 10.1046/j.1365-2141.1996.7052322.x 10.1016/0145-2126(85)90082-7 10.1089/scd.1.1996.5.213 10.1111/j.1749-6632.1995.tb31046.x 10.3109/10428199509075299 10.1089/scd.1.1996.5.599 10.4049/jimmunol.133.1.157 |
ContentType | Journal Article |
Copyright | Copyright © 2010 The Korean Association of Immunologists 2010 |
Copyright_xml | – notice: Copyright © 2010 The Korean Association of Immunologists 2010 |
DBID | DBRKI TDB AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.4110/in.2010.10.6.239 |
DatabaseName | DBPIA - 디비피아 Nurimedia DBPIA Journals CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2092-6685 |
EndPage | 246 |
ExternalDocumentID | oai_kci_go_kr_ARTI_230395 PMC3026944 21286385 10_4110_in_2010_10_6_239 NODE06392735 |
Genre | Journal Article |
GroupedDBID | 5-W 53G 8JR 8XY 9ZL ACYCR ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL DBRKI DIK E3Z EF. F5P GW5 HYE KQ8 KVFHK M48 MZR O5R O5S OK1 PGMZT RPM TDB ZZE AAYXX CITATION NPM 7X8 5PM .UV M~E |
ID | FETCH-LOGICAL-c3039-c9422f27069257e168fbaa0680d767fa15d7c14c6357a3b29a5d6ab4aa80491c3 |
IEDL.DBID | M48 |
ISSN | 1598-2629 2092-6685 |
IngestDate | Tue Nov 21 21:36:43 EST 2023 Thu Aug 21 18:18:50 EDT 2025 Thu Jul 10 17:10:29 EDT 2025 Thu Apr 03 07:01:24 EDT 2025 Thu Apr 24 22:54:43 EDT 2025 Tue Jul 01 00:45:51 EDT 2025 Thu Mar 13 19:40:02 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | 27H2 Class III epitope Monoclonal antibody Diagnosis CD34 Leukemia |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3039-c9422f27069257e168fbaa0680d767fa15d7c14c6357a3b29a5d6ab4aa80491c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-001562.2010.10.6.001 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4110/in.2010.10.6.239 |
PMID | 21286385 |
PQID | 849010016 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_230395 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3026944 proquest_miscellaneous_849010016 pubmed_primary_21286385 crossref_citationtrail_10_4110_in_2010_10_6_239 crossref_primary_10_4110_in_2010_10_6_239 nurimedia_primary_NODE06392735 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20101201 |
PublicationDateYYYYMMDD | 2010-12-01 |
PublicationDate_xml | – month: 12 year: 2010 text: 20101201 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Immune network |
PublicationTitleAlternate | Immune Netw |
PublicationYear | 2010 |
Publisher | 대한면역학회 The Korean Association of Immunologists |
Publisher_xml | – name: 대한면역학회 – name: The Korean Association of Immunologists |
References | Watt (10.4110/in.2010.10.6.239_ref3) 1987; 1 Steen (10.4110/in.2010.10.6.239_ref21) 1996; 94 Katz (10.4110/in.2010.10.6.239_ref11) 1985; 9 Shpall (10.4110/in.2010.10.6.239_ref12) 1994; 12 Civin (10.4110/in.2010.10.6.239_ref6) 1995; 770 Serke (10.4110/in.2010.10.6.239_ref20) 1996; 26 Vescio (10.4110/in.2010.10.6.239_ref13) 1999; 93 Greaves (10.4110/in.2010.10.6.239_ref15) 1995 Beschorner (10.4110/in.2010.10.6.239_ref4) 1985; 119 Tindle (10.4110/in.2010.10.6.239_ref2) 1985; 9 Siena (10.4110/in.2010.10.6.239_ref10) 1991; 76 Titley (10.4110/in.2010.10.6.239_ref17) 1995; 16 Civin (10.4110/in.2010.10.6.239_ref14) 1989 Sutherland (10.4110/in.2010.10.6.239_ref26) 2000 Macey (10.4110/in.2010.10.6.239_ref24) 1997; 204 Sutherland (10.4110/in.2010.10.6.239_ref9) 1996; 5 Lanza (10.4110/in.2010.10.6.239_ref22) 1995; 18 Greaves (10.4110/in.2010.10.6.239_ref7) 1992; 6 Cannovo (10.4110/in.2010.10.6.239_ref19) 1997; 3 Fina (10.4110/in.2010.10.6.239_ref5) 1990; 75 Sovalat (10.4110/in.2010.10.6.239_ref25) 1998; 40 Sutherland (10.4110/in.2010.10.6.239_ref8) 1992; 1 Titley (10.4110/in.2010.10.6.239_ref18) 1995; 16 Nishio (10.4110/in.2010.10.6.239_ref16) 1997 Lanza (10.4110/in.2010.10.6.239_ref27) 2001; 15 Weinberg (10.4110/in.2010.10.6.239_ref23) 1996; 5 Civin (10.4110/in.2010.10.6.239_ref1) 1984; 133 1724439 - Haematologica. 1991 Jul-Aug;76(4):330-3 1693532 - Blood. 1990 Jun 15;75(12):2417-26 10068658 - Blood. 1999 Mar 15;93(6):1858-68 7505806 - J Clin Oncol. 1994 Jan;12(1):28-36 8817388 - J Hematother. 1996 Jun;5(3):213-26 1372379 - Leukemia. 1992;6 Suppl 1:31-6 7496351 - Leuk Lymphoma. 1995;18 Suppl 1:25-30 8528180 - Bone Marrow Transplant. 1995 Oct;16(4):611-6 8826880 - Br J Haematol. 1996 Sep;94(4):597-605 6586833 - J Immunol. 1984 Jul;133(1):157-65 3857408 - Leuk Res. 1985;9(2):191-8 11388737 - J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):1-13 9212835 - J Immunol Methods. 1997 May 26;204(2):175-88 2444831 - Leukemia. 1987 May;1(5):417-26 3857402 - Leuk Res. 1985;9(1):1-9 8597386 - Ann N Y Acad Sci. 1995 Dec 29;770:91-8 1285404 - J Hematother. 1992 Summer;1(2):115-29 8817092 - Cytometry. 1996 Jun 15;26(2):154-60 9117248 - J Hematother. 1996 Dec;5(6):599-603 3885751 - Am J Pathol. 1985 Apr;119(1):1-4 9924925 - Hematol Cell Ther. 1998 Dec;40(6):259-68 |
References_xml | – volume: 9 start-page: 1 year: 1985 ident: 10.4110/in.2010.10.6.239_ref2 publication-title: Leuk Res doi: 10.1016/0145-2126(85)90016-5 – volume: 12 start-page: 28 year: 1994 ident: 10.4110/in.2010.10.6.239_ref12 publication-title: J Clin Oncol doi: 10.1200/JCO.1994.12.1.28 – start-page: 840 volume-title: Leukocyte Typing V year: 1995 ident: 10.4110/in.2010.10.6.239_ref15 – volume: 3 start-page: 253 year: 1997 ident: 10.4110/in.2010.10.6.239_ref19 publication-title: Lab Hematol – volume: 204 start-page: 175 year: 1997 ident: 10.4110/in.2010.10.6.239_ref24 publication-title: J Immunol Methods doi: 10.1016/S0022-1759(97)00045-8 – volume: 26 start-page: 154 year: 1996 ident: 10.4110/in.2010.10.6.239_ref20 publication-title: Cytometry doi: 10.1002/(SICI)1097-0320(19960615)26:2<154::AID-CYTO9>3.0.CO;2-G – volume: 75 start-page: 2417 year: 1990 ident: 10.4110/in.2010.10.6.239_ref5 publication-title: Blood doi: 10.1182/blood.V75.12.2417.2417 – volume: 16 start-page: 611 year: 1995 ident: 10.4110/in.2010.10.6.239_ref18 publication-title: Bone Marrow Transplant – volume: 1 start-page: 417 year: 1987 ident: 10.4110/in.2010.10.6.239_ref3 publication-title: Leukemia – start-page: 974 volume-title: MC7. CD34 workshop panel report year: 1997 ident: 10.4110/in.2010.10.6.239_ref16 – volume: 6 start-page: 31 issue: Suppl 1 year: 1992 ident: 10.4110/in.2010.10.6.239_ref7 publication-title: Leukemia – volume: 40 start-page: 259 year: 1998 ident: 10.4110/in.2010.10.6.239_ref25 publication-title: Hematol Cell Ther – start-page: 818 volume-title: M7.1. Report on the CD34 cluster workshop year: 1989 ident: 10.4110/in.2010.10.6.239_ref14 – volume: 1 start-page: 115 year: 1992 ident: 10.4110/in.2010.10.6.239_ref8 publication-title: J Hematother doi: 10.1089/scd.1.1992.1.115 – start-page: 239 volume-title: Bone Marrow Transplantation: A Practical Approach year: 2000 ident: 10.4110/in.2010.10.6.239_ref26 – volume: 16 start-page: 611 year: 1995 ident: 10.4110/in.2010.10.6.239_ref17 publication-title: Bone Marrow Transplant – volume: 94 start-page: 597 year: 1996 ident: 10.4110/in.2010.10.6.239_ref21 publication-title: Br J Haematol doi: 10.1046/j.1365-2141.1996.7052322.x – volume: 9 start-page: 191 year: 1985 ident: 10.4110/in.2010.10.6.239_ref11 publication-title: Leuk Res doi: 10.1016/0145-2126(85)90082-7 – volume: 5 start-page: 213 year: 1996 ident: 10.4110/in.2010.10.6.239_ref9 publication-title: J Hematother doi: 10.1089/scd.1.1996.5.213 – volume: 770 start-page: 91 year: 1995 ident: 10.4110/in.2010.10.6.239_ref6 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1995.tb31046.x – volume: 15 start-page: 1 year: 2001 ident: 10.4110/in.2010.10.6.239_ref27 publication-title: J Biol Regul Homeost Agents – volume: 76 start-page: 330 year: 1991 ident: 10.4110/in.2010.10.6.239_ref10 publication-title: Haematologica – volume: 18 start-page: 25 issue: Suppl 1 year: 1995 ident: 10.4110/in.2010.10.6.239_ref22 publication-title: Leuk Lymphoma doi: 10.3109/10428199509075299 – volume: 5 start-page: 599 year: 1996 ident: 10.4110/in.2010.10.6.239_ref23 publication-title: J Hematother doi: 10.1089/scd.1.1996.5.599 – volume: 93 start-page: 1858 year: 1999 ident: 10.4110/in.2010.10.6.239_ref13 publication-title: Blood – volume: 119 start-page: 1 year: 1985 ident: 10.4110/in.2010.10.6.239_ref4 publication-title: Am J Pathol – volume: 133 start-page: 157 year: 1984 ident: 10.4110/in.2010.10.6.239_ref1 publication-title: J Immunol doi: 10.4049/jimmunol.133.1.157 – reference: 1372379 - Leukemia. 1992;6 Suppl 1:31-6 – reference: 9212835 - J Immunol Methods. 1997 May 26;204(2):175-88 – reference: 8817092 - Cytometry. 1996 Jun 15;26(2):154-60 – reference: 7496351 - Leuk Lymphoma. 1995;18 Suppl 1:25-30 – reference: 1724439 - Haematologica. 1991 Jul-Aug;76(4):330-3 – reference: 2444831 - Leukemia. 1987 May;1(5):417-26 – reference: 3885751 - Am J Pathol. 1985 Apr;119(1):1-4 – reference: 8826880 - Br J Haematol. 1996 Sep;94(4):597-605 – reference: 11388737 - J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):1-13 – reference: 1693532 - Blood. 1990 Jun 15;75(12):2417-26 – reference: 8528180 - Bone Marrow Transplant. 1995 Oct;16(4):611-6 – reference: 9924925 - Hematol Cell Ther. 1998 Dec;40(6):259-68 – reference: 10068658 - Blood. 1999 Mar 15;93(6):1858-68 – reference: 8817388 - J Hematother. 1996 Jun;5(3):213-26 – reference: 1285404 - J Hematother. 1992 Summer;1(2):115-29 – reference: 9117248 - J Hematother. 1996 Dec;5(6):599-603 – reference: 6586833 - J Immunol. 1984 Jul;133(1):157-65 – reference: 3857408 - Leuk Res. 1985;9(2):191-8 – reference: 7505806 - J Clin Oncol. 1994 Jan;12(1):28-36 – reference: 3857402 - Leuk Res. 1985;9(1):1-9 – reference: 8597386 - Ann N Y Acad Sci. 1995 Dec 29;770:91-8 |
SSID | ssj0064375 |
Score | 1.747581 |
Snippet | Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.
27H2 mAb was developed from a mouse... Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.BACKGROUNDMonoclonal antibodies... Background: Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. Methods: 27H2 mAb was... |
SourceID | nrf pubmedcentral proquest pubmed crossref nurimedia |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 239 |
SubjectTerms | Original 면역학 |
Title | Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope |
URI | https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE06392735 https://www.ncbi.nlm.nih.gov/pubmed/21286385 https://www.proquest.com/docview/849010016 https://pubmed.ncbi.nlm.nih.gov/PMC3026944 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001518585 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Immune Network, 2010, 10(6), , pp.239-246 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1da9swUKwdY3sZ-172ETTYw_rg1JJlWX4aI01JBs1gLNA3IclyZxrkNE3Ksl-_Ozv1lhE2MDbGJ9nW6XR3ui9C3itZcCdTAYSUmQgzUkWqKFmUS2eLPI298xjvfDaV45n4fJ6e_w6P3g7g9V7VDutJzZbzwY-rzUcgeJBfBwK413EVWhctOOSAJ_kBuQt8SaIqdiY6mwJaqNChkcc5j6RUaWu03NvDDpM6CEs43w9rzLcPSNsni_7tUvkHjzp9RB5uhUv6qZ0Nj8kdH56Qe225yc1TooddduY2-JLWJTV0Wt_4OQXirt28btqHVWXrYkM_8GzMj-jX1snoJ3A52mz60-FJImhTT5NOJhM6WsC6sPDPyOx09G04jrYFFiKXoAXY5YLzkmexzIFyPZOqtMZgNY4ik1lpWFpkjgmHOetMYnlu0kIaK4xRoFgwlzwnh6EO_iWhsS-tLwvQ3ywTXnGbpz5TBWOJij3zrkeOb0dUu232cSyCMdeghSAOdBU04gDvpQYc9MhR12LRZt74B-w7QJK-dJXGdNl4vaj15VKDUjABAPjZtEf6HQq7DqdfTkYopIEQBwD0Fq8aaAwNJyb4en2tlUAnFhCOe-RFi-auA-D8CpYwaJztTIAOAL9n90movjdpvJMYo4jFq_-_9jV5wDsvmjfkcLVc-7cgC61sv5ni_WaT6hdu4QQW |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+a+Novel+Monoclonal+Antibody+%2827H2%29+Recognizing+Human+CD34+Class+III+Epitope&rft.jtitle=Immune+network&rft.au=Hong%2C+Kwon+Pyo&rft.au=Kang%2C+Sung+Hee&rft.au=Lee%2C+Kyoung-Mee&rft.au=Ji%2C+Gil+Yong&rft.date=2010-12-01&rft.issn=2092-6685&rft.eissn=2092-6685&rft.volume=10&rft.issue=6&rft.spage=239&rft_id=info:doi/10.4110%2Fin.2010.10.6.239&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2629&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2629&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2629&client=summon |